{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:41:27Z","timestamp":1790876487934,"version":"4.1.0"},"reference-count":94,"publisher":"Elsevier","isbn-type":[{"value":"9780443295201","type":"print"}],"license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/bs.enz.2024.05.005","type":"book-chapter","created":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T17:51:11Z","timestamp":1725731471000},"page":"261-280","source":"Crossref","is-referenced-by-count":17,"title":["Biomedical applications of tyrosinases and tyrosinase inhibitors"],"prefix":"10.1016","author":[{"given":"Luigi","family":"Pisano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Turco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/bs.enz.2024.05.005_bib1","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.3390\/ijms17071144","article-title":"Signaling pathways in melanogenesis","volume":"17","author":"D\u2019Mello","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/bs.enz.2024.05.005_bib2","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1590\/S0365-05962013000100009","article-title":"Mechanisms regulating melanogenesis","volume":"88","author":"Videira","year":"2013","journal-title":"An. Bras. Dermatol."},{"issue":"0)","key":"10.1016\/bs.enz.2024.05.005_bib3","doi-asserted-by":"crossref","first-page":"695","DOI":"10.5604\/17322693.1208033","article-title":"From tyrosine to melanin: signaling pathways and factors regulating melanogenesis","volume":"70","author":"Rzepka","year":"2016","journal-title":"Postepy Hig. Med. Dosw. (Online)"},{"issue":"5","key":"10.1016\/bs.enz.2024.05.005_bib4","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1034\/j.1600-0749.2003.00072.x","article-title":"Quantitative analysis of eumelanin and pheomelanin in humans, mice, and other animals: a comparative review","volume":"16","author":"Ito","year":"2003","journal-title":"Pigment. Cell Res."},{"issue":"3","key":"10.1016\/bs.enz.2024.05.005_bib5","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1600-0749.2005.00233.x","article-title":"Eumelanin and pheomelanin concentrations in human epidermis before and after UVB irradiation","volume":"18","author":"Hennessy","year":"2005","journal-title":"Pigment. Cell Res."},{"key":"10.1016\/bs.enz.2024.05.005_bib6","doi-asserted-by":"crossref","DOI":"10.1111\/pcmr.13165","article-title":"The metabolism of melanin synthesis\u2014from melanocytes to melanoma","author":"Snyman","year":"2024","journal-title":"Pigment. Cell Melanoma Res."},{"issue":"1","key":"10.1016\/bs.enz.2024.05.005_bib7","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1080\/14756366.2018.1545767","article-title":"A comprehensive review on tyrosinase inhibitors","volume":"34","author":"Zolghadri","year":"2019","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"8","key":"10.1016\/bs.enz.2024.05.005_bib8","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1016\/j.bmc.2014.02.048","article-title":"Tyrosinase: the four oxidation states of the active site and their relevance to enzymatic activation, oxidation and inactivation","volume":"22","author":"Ramsden","year":"2014","journal-title":"Bioorg Med. Chem."},{"issue":"2","key":"10.1016\/bs.enz.2024.05.005_bib9","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.drudis.2016.09.016","article-title":"Downregulation of melanogenesis: drug discovery and therapeutic options","volume":"22","author":"Pillaiyar","year":"2017","journal-title":"Drug. Discov. Today"},{"issue":"12","key":"10.1016\/bs.enz.2024.05.005_bib10","doi-asserted-by":"crossref","first-page":"4839","DOI":"10.3390\/molecules28124839","article-title":"Skin pigmentation types, causes and treatment\u2014a review","volume":"28","author":"Thawabteh","year":"2023","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/bs.enz.2024.05.005_bib11","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1111\/pcmr.12986","article-title":"Management of hyperpigmentation: current treatments and emerging therapies","volume":"34","author":"Nautiyal","year":"2021","journal-title":"Pigment. Cell Melanoma Res."},{"issue":"3","key":"10.1016\/bs.enz.2024.05.005_bib12","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.det.2007.04.013","article-title":"Origin, clinical presentation, and diagnosis of hypomelanotic skin disorders","volume":"25","author":"Mollet","year":"2007","journal-title":"Dermatol. Clin."},{"issue":"3","key":"10.1016\/bs.enz.2024.05.005_bib13","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.det.2023.02.006","article-title":"Diagnosing disorders of hypopigmentation and depigmentation in patients with skin of color","volume":"41","author":"Ceresnie","year":"2023","journal-title":"Dermatol. Clin."},{"issue":"3","key":"10.1016\/bs.enz.2024.05.005_bib14","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s12016-021-08868-z","article-title":"Clinical features, immunopathogenesis, and therapeutic strategies in vitiligo","volume":"61","author":"Wang","year":"2021","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"4","key":"10.1016\/bs.enz.2024.05.005_bib15","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.autrev.2015.12.006","article-title":"Vitiligo: pathogenesis, clinical variants and treatment approaches","volume":"15","author":"Iannella","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/bs.enz.2024.05.005_bib16","doi-asserted-by":"crossref","DOI":"10.1111\/ijd.17148","article-title":"Vitiligo and psychological stress: a hypothesis integrating the neuroendocrine and immune systems in melanocyte destruction","author":"Al Abadie","year":"2024","journal-title":"Int. J. Dermatol."},{"issue":"5","key":"10.1016\/bs.enz.2024.05.005_bib17","doi-asserted-by":"crossref","first-page":"4910","DOI":"10.3390\/ijms24054910","article-title":"Vitiligo, from pathogenesis to therapeutic advances: State of the art","volume":"24","author":"Diotallevi","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/bs.enz.2024.05.005_bib18","series-title":"StatPearls [Internet]","article-title":"Idiopathic guttate hypomelanosis","author":"Brown","year":"2024"},{"issue":"1-2","key":"10.1016\/bs.enz.2024.05.005_bib19","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1080\/14764172.2021.1957116","article-title":"Idiopathic guttate hypomelanosis: presentation and management","volume":"23","author":"Buch","year":"2021","journal-title":"J. Cosmet. Laser Ther."},{"issue":"5","key":"10.1016\/bs.enz.2024.05.005_bib20","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.jaad.2003.12.034","article-title":"Skin diseases associated with Malassezia species","volume":"51","author":"Gupta","year":"2004","journal-title":"J. Am. Acad. Dermatol."},{"issue":"2","key":"10.1016\/bs.enz.2024.05.005_bib21","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/01.qco.0000216624.21069.61","article-title":"Malassezia yeasts and pityriasis versicolor","volume":"19","author":"Crespo-Erchiga","year":"2006","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/bs.enz.2024.05.005_bib22","series-title":"StatPearls [Internet]","article-title":"Pityriasis alba","author":"Givler","year":"2024"},{"issue":"3","key":"10.1016\/bs.enz.2024.05.005_bib23","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.3390\/jcm12031243","article-title":"Post-inflammatory hypopigmentation: Review of the etiology, clinical manifestations, and treatment options","volume":"12","author":"Rao","year":"2023","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/bs.enz.2024.05.005_bib24","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1590\/abd1806-4841.20142353","article-title":"Acquired hyperpigmentations","volume":"89","author":"Cestari","year":"2014","journal-title":"An. Bras. Dermatol."},{"issue":"5","key":"10.1016\/bs.enz.2024.05.005_bib25","doi-asserted-by":"crossref","first-page":"487","DOI":"10.4103\/0019-5154.190103","article-title":"Skin hyperpigmentation in Indian population: Insights and best practice","volume":"61","author":"Nouveau","year":"2016","journal-title":"Indian J. Dermatol."},{"issue":"4","key":"10.1016\/bs.enz.2024.05.005_bib26","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/pcmr.12684","article-title":"Melasma, a photoaging disorder","volume":"31","author":"Passeron","year":"2018","journal-title":"Pigment. Cell Melanoma Res."},{"issue":"10","key":"10.1016\/bs.enz.2024.05.005_bib27","doi-asserted-by":"crossref","DOI":"10.5070\/D32510045810","article-title":"Melasma pathogenesis: a review of the latest research, pathological findings, and investigational therapies","volume":"25","author":"Rajanala","year":"2019","journal-title":"Dermatol. Online J."},{"issue":"2","key":"10.1016\/bs.enz.2024.05.005_bib28","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s40257-019-00488-w","article-title":"Melasma treatment: an evidence-based review","volume":"21","author":"McKesey","year":"2020","journal-title":"Am. J. Clin. Dermatol."},{"issue":"4","key":"10.1016\/bs.enz.2024.05.005_bib29","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1080\/09546634.2021.1914313","article-title":"Melasma treatment: a systematic review","volume":"33","author":"Neagu","year":"2022","journal-title":"J. Dermatol. Treat."},{"issue":"12","key":"10.1016\/bs.enz.2024.05.005_bib30","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1111\/1346-8138.16080","article-title":"Thiamidol\u00ae in moderate-to-severe melasma: 24-week, randomized, double-blind, vehicle-controlled clinical study with subsequent regression phase","volume":"48","author":"Roggenkamp","year":"2021","journal-title":"J. Dermatol."},{"issue":"5","key":"10.1016\/bs.enz.2024.05.005_bib31","article-title":"Solar lentigines: sun-damaged skin on the hand","volume":"89","author":"Sevilla","year":"2023","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"issue":"1","key":"10.1016\/bs.enz.2024.05.005_bib32","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/DSS.0000000000003630","article-title":"Treatment of lentigines: a systematic review","volume":"49","author":"Mukovozov","year":"2023","journal-title":"Dermatol. Surg."},{"issue":"5 Suppl 2","key":"10.1016\/bs.enz.2024.05.005_bib33","doi-asserted-by":"crossref","first-page":"S262","DOI":"10.1016\/j.jaad.2005.12.043","article-title":"Treatment of solar lentigines","volume":"54","author":"Ortonne","year":"2006","journal-title":"J. Am. Acad. Dermatol."},{"issue":"6","key":"10.1016\/bs.enz.2024.05.005_bib34","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s40257-021-00633-4","article-title":"The pathogenesis and management of acne-induced post-inflammatory hyperpigmentation","volume":"22","author":"Elbuluk","year":"2021","journal-title":"Am. J. Clin. Dermatol."},{"issue":"8","key":"10.1016\/bs.enz.2024.05.005_bib35","doi-asserted-by":"crossref","first-page":"763","DOI":"10.36849\/JDD.2020.4887","article-title":"Post-inflammatory hyperpigmentation: a review of treatment strategies","volume":"19","author":"Shenoy","year":"2020","journal-title":"J. Drugs Dermatol."},{"issue":"1","key":"10.1016\/bs.enz.2024.05.005_bib36","first-page":"1","article-title":"Melasma and post inflammatory hyperpigmentation: management update and expert opinion","volume":"21","author":"Sofen","year":"2016","journal-title":"Skin. Ther. Lett."},{"issue":"1","key":"10.1016\/bs.enz.2024.05.005_bib37","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/DSS.0000000000002484","article-title":"Treatments of periorbital hyperpigmentation: a systematic review","volume":"47","author":"Michelle","year":"2021","journal-title":"Dermatol. Surg."},{"issue":"4","key":"10.1016\/bs.enz.2024.05.005_bib38","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.1468-3083.2005.01213.x","article-title":"Poikiloderma of Civatte: a clinical and epidemiological study","volume":"19","author":"Katoulis","year":"2005","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"1","key":"10.1016\/bs.enz.2024.05.005_bib39","doi-asserted-by":"crossref","first-page":"68","DOI":"10.2174\/1573396318666220429085231","article-title":"Acanthosis Nigricans: an updated review","volume":"19","author":"Leung","year":"2022","journal-title":"Curr. Pediatr. Rev."},{"issue":"8","key":"10.1016\/bs.enz.2024.05.005_bib40","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1111\/jocd.13544","article-title":"Acanthosis nigricans: a review","volume":"19","author":"Das","year":"2020","journal-title":"J. Cosmet. Dermatol."},{"issue":"3","key":"10.1016\/bs.enz.2024.05.005_bib41","first-page":"161","article-title":"Diagnosis and treatment of Acanthosis nigricans","volume":"8","author":"Kapoor","year":"2010","journal-title":"Skinmed"},{"key":"10.1016\/bs.enz.2024.05.005_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2024.149785","article-title":"Tyrosinase regulates the motility of human melanoma cell line A375 through its hydroxylase enzymatic activity","volume":"707","author":"Honda","year":"2024","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"11","key":"10.1016\/bs.enz.2024.05.005_bib43","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1038\/ncb3623","article-title":"A non-coding function of TYRP1 mRNA promotes melanoma growth","volume":"19","author":"Gilot","year":"2017","journal-title":"Nat. Cell Biol."},{"issue":"5","key":"10.1016\/bs.enz.2024.05.005_bib44","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3892\/ol.2022.13289","article-title":"Tyrosinase suppresses vasculogenic mimicry in human melanoma cells","volume":"23","author":"Kamo","year":"2022","journal-title":"Oncol. Lett."},{"issue":"48","key":"10.1016\/bs.enz.2024.05.005_bib45","doi-asserted-by":"crossref","first-page":"31801","DOI":"10.1074\/jbc.273.48.31801","article-title":"Tyrosinase stabilization by Tyrp1 (the brown locus protein)","volume":"273","author":"Kobayashi","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/bs.enz.2024.05.005_bib46","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1021\/acsmedchemlett.1c00252","article-title":"Sulfur analogues of tyrosine in the development of triazene hybrid compounds: a new strategy against melanoma","volume":"12","author":"Granada","year":"2021","journal-title":"ACS Med. Chem. Lett."},{"issue":"24","key":"10.1016\/bs.enz.2024.05.005_bib47","doi-asserted-by":"crossref","first-page":"7546","DOI":"10.3390\/molecules26247546","article-title":"Insights on the inhibitory power of flavonoids on tyrosinase activity: a survey from 2016 to 2021","volume":"26","author":"El-Nashar","year":"2021","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/bs.enz.2024.05.005_bib48","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1021\/acsabm.0c01322","article-title":"Phenylthiourea-conjugated BODIPY as an efficient photosensitizer for tyrosinase-positive melanoma-targeted photodynamic therapy","volume":"4","author":"Jung","year":"2021","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/bs.enz.2024.05.005_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114147","article-title":"Cinnamic acid derivatives linked to arylpiperazines as novel potent inhibitors of tyrosinase activity and melanin synthesis","volume":"231","author":"Romagnoli","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/bs.enz.2024.05.005_bib50","article-title":"Discovery of novel tyrosinase inhibitors from marine cyanobacteria","volume":"13","author":"He","year":"2022","journal-title":"Front. Microbiol."},{"issue":"7","key":"10.1016\/bs.enz.2024.05.005_bib51","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.7150\/ijms.72241","article-title":"Catechin-7-O-\u03b1-L-rhamnopyranoside can reduce \u03b1-MSH-induced melanogenesis in B16F10 melanoma cells through competitive inhibition of tyrosinase","volume":"19","author":"Hwang","year":"2022","journal-title":"Int. J. Med. Sci."},{"issue":"6","key":"10.1016\/bs.enz.2024.05.005_bib52","doi-asserted-by":"crossref","first-page":"5235","DOI":"10.3390\/ijms24065235","article-title":"A sulfur containing melanogenesis substrate, N-Pr-4-S-CAP as a potential source for selective chemoimmunotherapy of malignant melanoma","volume":"24","author":"Tamura","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"23","key":"10.1016\/bs.enz.2024.05.005_bib53","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202300327","article-title":"Tyrosinase-activated nanocomposites for double-modals imaging guided photodynamic and photothermal synergistic therapy","volume":"12","author":"Li","year":"2023","journal-title":"Adv. Healthc. Mater."},{"issue":"1","key":"10.1016\/bs.enz.2024.05.005_bib54","doi-asserted-by":"crossref","DOI":"10.1080\/14756366.2023.2205042","article-title":"Synthesis, in silico modelling, and in vitro biological evaluation of substituted pyrazole derivatives as potential anti-skin cancer, anti-tyrosinase, and antioxidant agents","volume":"38","author":"Boateng","year":"2023","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"6","key":"10.1016\/bs.enz.2024.05.005_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2023.188968","article-title":"Natural tyrosinase enzyme inhibitors: a path from melanin to melanoma and its reported pharmacological activities","volume":"1878","author":"Logesh","year":"2023","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/bs.enz.2024.05.005_bib56","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1255586","article-title":"Maltol has anti-cancer effects via modulating PD-L1 signaling pathway in B16F10 cells","volume":"14","author":"Han","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/bs.enz.2024.05.005_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2023.117537","article-title":"Beyond traditional methods: unveiling the skin whitening properties of rhein-embedded PROTACs","volume":"96","author":"Xu","year":"2023","journal-title":"Bioorg Med. Chem."},{"key":"10.1016\/bs.enz.2024.05.005_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116165","article-title":"Design and synthesis of 4-amino-2\u2019,4\u2019-dihydroxyindanone derivatives as potent inhibitors of tyrosinase and melanin biosynthesis in human melanoma cells","volume":"266","author":"Lazinski","year":"2024","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/bs.enz.2024.05.005_bib59","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1038\/s41467-024-45221-2","article-title":"CAR-T cell therapy targeting surface expression of TYRP1 to treat cutaneous and rare melanoma subtypes","volume":"15","author":"Jilani","year":"2024","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/bs.enz.2024.05.005_bib60","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1080\/14756360500179333","article-title":"Tyrosinase inhibition: conformational analysis based studies on molecular dynamics calculations of bipiperidine based inhibitors","volume":"20","author":"Khan","year":"2005","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"1","key":"10.1016\/bs.enz.2024.05.005_bib61","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1080\/14756366.2019.1707196","article-title":"Sulphonamides incorporating 1,3,5-triazine structural motifs show antioxidant, acetylcholinesterase, butyrylcholinesterase, and tyrosinase inhibitory profile","volume":"35","author":"Lolak","year":"2020","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"1","key":"10.1016\/bs.enz.2024.05.005_bib62","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1080\/14756366.2020.1765166","article-title":"Synthesis of calix[4]azacrown substituted sulphonamides with antioxidant, acetylcholinesterase, butyrylcholinesterase, tyrosinase and carbonic anhydrase inhibitory action","volume":"35","author":"Oguz","year":"2020","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"1","key":"10.1016\/bs.enz.2024.05.005_bib63","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1080\/14756366.2021.2014832","article-title":"Flavonoids as tyrosinase inhibitors in in silico and in vitro models: basic framework of SAR using a statistical modelling approach","volume":"37","author":"Jakimiuk","year":"2022","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"17","key":"10.1016\/bs.enz.2024.05.005_bib64","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1016\/j.vaccine.2020.02.034","article-title":"Therapeutic efficacy of PD1\/PDL1 blockade in B16 melanoma is greatly enhanced by immunization with dendritic cell-targeting lentiviral vector and protein vaccine","volume":"38","author":"Albershardt","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/bs.enz.2024.05.005_bib65","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.869078","article-title":"Imprime PGG enhances anti-tumor effects of tumor-targeting, anti-angiogenic, and immune checkpoint inhibitor antibodies","volume":"12","author":"Chan","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/bs.enz.2024.05.005_bib66","series-title":"Metalloenzymes\u2014From Bench to Bedside","first-page":"533","article-title":"Tyrosinase enzyme and its inhibitors: an update of the litearture","author":"Carradori","year":"2024"},{"issue":"1","key":"10.1016\/bs.enz.2024.05.005_bib67","doi-asserted-by":"crossref","DOI":"10.1080\/14756366.2023.2269611","volume":"38","author":"Wojtasek","year":"2023","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"1","key":"10.1016\/bs.enz.2024.05.005_bib68","doi-asserted-by":"crossref","DOI":"10.1080\/14756366.2023.2269613","volume":"38","author":"Tomczyk","year":"2023","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"11","key":"10.1016\/bs.enz.2024.05.005_bib69","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1248\/cpb.c23-00410","article-title":"A fluorescence biosensor for tyrosinase activity analysis based on silicon-doped carbon quantum dots","volume":"71","author":"Chen","year":"2023","journal-title":"Chem. Pharm. Bull. (Tokyo)"},{"issue":"18","key":"10.1016\/bs.enz.2024.05.005_bib70","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1007\/s00216-023-04710-x","article-title":"Simple and rapid detection of tyrosinase activity with the adjustable light scattering properties of CoOOH nanoflakes","volume":"415","author":"Li","year":"2023","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/bs.enz.2024.05.005_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2022.124175","article-title":"A blue\/NIR ratiometric fluorescent probe for intracellular detection of Tyrosinase and the inhibitor screening","volume":"254","author":"Dai","year":"2023","journal-title":"Talanta"},{"issue":"8","key":"10.1016\/bs.enz.2024.05.005_bib72","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3390\/bios11080290","article-title":"Spectrophotometric assays for sensing tyrosinase activity and their applications","volume":"11","author":"Fan","year":"2021","journal-title":"Biosens (Basel)"},{"issue":"1","key":"10.1016\/bs.enz.2024.05.005_bib73","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/jpp\/rgad107","article-title":"Dysregulation of tyrosinase activity: a potential link between skin disorders and neurodegeneration","volume":"76","author":"Jin","year":"2024","journal-title":"J. Pharm. Pharmacol."},{"issue":"10","key":"10.1016\/bs.enz.2024.05.005_bib74","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1111\/exd.14662","article-title":"Biological activities and safety data of kojic acid and its derivatives: a review","volume":"31","author":"Zilles","year":"2022","journal-title":"Exp. Dermatol."},{"issue":"7","key":"10.1016\/bs.enz.2024.05.005_bib75","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.jid.2018.01.019","article-title":"Inhibition of human tyrosinase requires molecular motifs distinctively different from mushroom tyrosinase","volume":"138","author":"Mann","year":"2018","journal-title":"J. Invest. Dermatol."},{"issue":"8","key":"10.1016\/bs.enz.2024.05.005_bib76","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/j.jid.2019.02.013","article-title":"Effective tyrosinase inhibition by thiamidol results in significant improvement of mild to moderate melasma","volume":"139","author":"Arrowitz","year":"2019","journal-title":"J. Invest. Dermatol."},{"issue":"4","key":"10.1016\/bs.enz.2024.05.005_bib77","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/ics.12626","article-title":"Thiamidol containing treatment regimens in facial hyperpigmentation: an international multi-centre approach consisting of a double-blind, controlled, split-face study and of an open-label, real-world study","volume":"42","author":"Philipp-Dormston","year":"2020","journal-title":"Int. J. Cosmet. Sci."},{"issue":"9","key":"10.1016\/bs.enz.2024.05.005_bib78","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1111\/jdv.17344","article-title":"Efficacy and safety of topical isobutylamido thiazolyl resorcinol (Thiamidol) vs. 4% hydroquinone cream for facial melasma: an evaluator-blinded, randomized controlled trial","volume":"35","author":"Lima","year":"2021","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"2","key":"10.1016\/bs.enz.2024.05.005_bib79","doi-asserted-by":"crossref","first-page":"972","DOI":"10.3390\/ijms25020972","article-title":"6\u2019-O-Caffeoylarbutin from Quezui tea: a highly effective and safe tyrosinase inhibitor","volume":"25","author":"Xie","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/bs.enz.2024.05.005_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2024.138430","article-title":"Cyrene\u2122 as a tyrosinase inhibitor and anti-browning agent","volume":"442","author":"Cytarska","year":"2024","journal-title":"Food Chem."},{"key":"10.1016\/bs.enz.2024.05.005_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.128229","article-title":"Methyl 4-pyridyl ketone thiosemicarbazone (4-PT) as an effective and safe inhibitor of mushroom tyrosinase and antibrowning agent","volume":"255","author":"Hassanuddin","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/bs.enz.2024.05.005_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.126451","article-title":"Exploring the effect of a series of flavonoids on tyrosinase using integrated enzyme kinetics, multispectroscopic, and molecular modelling analyses","volume":"252","author":"Chen","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/bs.enz.2024.05.005_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2023.136106","article-title":"Anti-browning and antibacterial dual functions of novel hydroxypyranone-thiosemicarbazone derivatives as shrimp preservative agents: Synthesis, bio-evaluation, mechanism, and application","volume":"419","author":"Peng","year":"2023","journal-title":"Food Chem."},{"key":"10.1016\/bs.enz.2024.05.005_bib84","article-title":"Tyrosinase inhibitory mechanism and anti-browning properties of novel kojic acid derivatives bearing aromatic aldehyde moiety","volume":"6","author":"Peng","year":"2022","journal-title":"Curr. Res. Food Sci."},{"key":"10.1016\/bs.enz.2024.05.005_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2022.135275","article-title":"Synthesis and biological evaluation of new kojic acid-1,3,4-oxadiazole hybrids as tyrosinase inhibitors and their application in the anti-browning of fresh-cut mushrooms","volume":"409","author":"Wang","year":"2023","journal-title":"Food Chem."},{"key":"10.1016\/bs.enz.2024.05.005_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2024.138866","article-title":"Exogenous chlorogenic acid inhibits quality deterioration in fresh-cut potato slices","volume":"446","author":"You","year":"2024","journal-title":"Food Chem."},{"key":"10.1016\/bs.enz.2024.05.005_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.fochx.2024.101128","article-title":"Synthesis, anti-browning effect and mechanism research of kojic acid-coumarin derivatives as anti-tyrosinase inhibitors","volume":"21","author":"He","year":"2024","journal-title":"Food Chem. X"},{"issue":"1","key":"10.1016\/bs.enz.2024.05.005_bib88","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.syapm.2005.07.012","article-title":"Bacterial tyrosinases","volume":"29","author":"Claus","year":"2006","journal-title":"Syst. Appl. Microbiol."},{"issue":"2","key":"10.1016\/bs.enz.2024.05.005_bib89","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.nbt.2011.05.007","article-title":"Bacterial tyrosinases: old enzymes with new relevance to biotechnology","volume":"29","author":"Fairhead","year":"2012","journal-title":"N. Biotechnol."},{"issue":"1","key":"10.1016\/bs.enz.2024.05.005_bib90","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s11274-023-03796-w","article-title":"Tyrosinase enzyme purification and immobilization from Pseudomonas sp. EG22 using cellulose coated magnetic nanoparticles: characterization and application in melanin production","volume":"40","author":"El-Aziz","year":"2023","journal-title":"World J. Microbiol. Biotechnol."},{"issue":"9","key":"10.1016\/bs.enz.2024.05.005_bib91","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.3390\/biom13091360","article-title":"The crystal structure of tyrosinase from Verrucomicrobium spinosum reveals it to be an atypical bacterial tyrosinase","volume":"13","author":"Fekry","year":"2023","journal-title":"Biomolecules"},{"issue":"2","key":"10.1016\/bs.enz.2024.05.005_bib92","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3390\/microorganisms12020297","article-title":"Biotechnological production and characterization of extracellular melanin by Streptomyces nashvillensis","volume":"12","author":"Restaino","year":"2024","journal-title":"Microorganisms"},{"issue":"1","key":"10.1016\/bs.enz.2024.05.005_bib93","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s11274-021-03186-0","article-title":"Application of bacterial tyrosinases in organic synthesis","volume":"38","author":"Agunbiade","year":"2021","journal-title":"World J. Microbiol. Biotechnol."},{"issue":"10","key":"10.1016\/bs.enz.2024.05.005_bib94","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.3390\/biomedicines11102739","article-title":"Bacterial tyrosinase inhibition, hemolytic and thrombolytic screening, and in silico modeling of rationally designed tosyl piperazine-engrafted dithiocarbamate derivatives","volume":"11","author":"Zahoor","year":"2023","journal-title":"Biomedicines"}],"container-title":["The Enzymes","Tyrosinase"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1874604724000052?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1874604724000052?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T23:52:02Z","timestamp":1726703522000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1874604724000052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"ISBN":["9780443295201"],"references-count":94,"URL":"https:\/\/doi.org\/10.1016\/bs.enz.2024.05.005","relation":{},"ISSN":["1874-6047"],"issn-type":[{"value":"1874-6047","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]}}}